20201208 China News
Source: | Author:eacham | Published time: 2020-12-08 | 939 Views | Share:
China Evergrande Group, one of the country's leading developers, reported surging sales last month, the company said in a statement. Its contracted sales in November totaled 46.07 billion yuan (about $7.03 billion), up 24.3 percent year-on-year, according to the company.


China Jinmao, a Hong Kong-listed real estate company, is committed to a strategic plan in the development of Hainan, especially the construction of Yazhou Bay in Sanya. Under the theme of "Rebirth of the City", the top management of China Jinmao shared their insights about their participation in the construction of Hainan on Saturday.


Guangzhou, Guangdong province-based EHang Holdings Limited, a manufacturer of autonomous aerial vehicles, or AAVs that are basically specialist drones with niche applications, is expanding in the global urban air mobility industry. EHang also provides commercial solutions in the form of air mobility, including passenger transportation and logistics, smart city management and aerial media solutions.


China's medical equipment industry saw a total revenue of more than 720 billion yuan (about $109.9 billion) in 2019, an industry report showed.The revenue was 12 percent higher than that in 2018, according to a report released by the China Society for Drug Regulation (CSDR).


China has rolled a 400 kilometers per hour high-speed train off the production line at CRRC Tangshan Co Ltd. The high-speed train can cope with different rail systems on international routes, making international rail travel more convenient, and operate in temperatures between minus 25 degrees Celsius and 50 degrees Celsius.


China saw its foreign trade grow 1.8 percent on a yearly basis to 29.04 trillion yuan ($4.17 trillion) between January and November, with exports surging 3.7 percent and imports declining 0.5 percent according to data released by the General Administration of Customs on Monday.


Sinovac Biotech Ltd, a leading provider of biopharmaceutical products in China, announced Monday that Sinovac Life Sciences Co Ltd, a Sinovac subsidiary, has secured approximately $500 million in funding for further development, capacity expansion and manufacturing of CoronaVac, its COVID-19 vaccine candidate, as well as conduct other development and operational activities.

Source:Globaltimes,Xinhuanet,Chinadaily,Shine,Gdtoday，China Plus News

Author: Producer Emilio Mendez

Speaker: Caroline Parraguez

Edition: EAcham

Guangzhou Office:
Suite 1816-1819, Guangzhou International Sourcing Center, No. 8 Pazhou Avenue East ,Haizhu District, Guangzhou, Guangdong Province.
Tel：+86-20-89059525

E-mail：gz@eacham.org

Shanghai Office:

Global Chambers Zone 

No.624C of Office Building B, National Convention and Exhibition Center(Shanghai)

Tel：+86-13917039347

E-mail：shanghai@eacham.org

Contact us
Beijing Office:

Room 607, No,1 East International Building, No,1 Ciyunsi, Chaoyang District, Beijing.

Tel：+86-10-64952381

Fax：+86-10-64958922
E-mail：info@eacham.org